NORTH READING, Mass., Feb. 14, 2017 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connectingthe life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, today announced financial and company results for the fourth quarter of 2016.
Quarterly and annual growth highlights for 2016 include:
"Our primary goal in 2016 was to expand our business globally across each segment of the supply chain. The sales momentum we achieved worldwide in the fourth quarter and for the year, demonstrates how our leadership position is accelerating," said Shabbir Dahod, president and CEO, TraceLink. "Through our market leadership, innovative digital supply chain network, and outstanding customer service, we will continue to partner with our customers and the industry to address their challenges in achieving regulatory compliance for all of the global markets they serve."
Additional growth highlights for 2016 include:
About TraceLinkTraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses, including 16 of the top-20 global pharmaceutical companies, trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte's Technology Fast 500 (ranked number 293 in 2015), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by FirstMark Capital, Volition Capital, F-Prime Capital, and Goldman Sachs.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/tracelink-reports-record-year-over-year-new-sales-bookings-and-97-growth-in-new-customers-for-2016-300406709.html
Subscribe to our Free Newsletters!
Myomectomy is a surgery that is done to remove fibroids, which are non-cancerous growths of the ...
Rosacea is a chronic skin condition marked by facial redness and swelling especially around the ...
Immunotherapy is a type of treatment method that works by using certain components of a person's ...View All